Oncology PracticeFDA proposes new breast implant labeling with a boxed warningOctober 24, 2019Patient & Survivor CareLymphoma & Plasma Cell Disorders
Hematology NewsFDA approves rivaroxaban for VTE prevention in hospitalized, acutely ill patientsOctober 15, 2019Thrombosis
Hematology NewsDaratumumab approved in combo with VTd for transplant-eligible multiple myelomaSeptember 26, 2019Multiple MyelomaTransplantLymphoma & Plasma Cell Disorders
Hematology NewsCDC awards $1.2 million to learn about people with sickle cell diseaseSeptember 26, 2019Anemia
Oncology PracticeFDA approves pembrolizumab/lenvatinib combo for advanced endometrial carcinomaSeptember 17, 2019Gynecologic Cancer
Hematology NewsCalquence earns breakthrough designation for CLL monotherapyAugust 27, 2019CLLB Cell LymphomaLeukemia, Myelodysplasia, Transplantation
Hematology NewsNew transfusion guidelines for thalassemiaAugust 16, 2019Bleeding DisordersBlood BankingTransfusion Medicine
Oncology PracticeFDA approves Turalio for symptomatic tenosynovial giant cell tumorAugust 2, 2019Sarcoma & GISTRare Diseases
Oncology PracticeHHS proposes pathways for drug importationJuly 31, 2019Practice ManagementBusiness of MedicinePatient & Survivor Care
Oncology PracticeLymphoma risk prompts FDA recall of Allergan’s textured breast implantsJuly 24, 2019Lymphoma & Plasma Cell DisordersT Cell Lymphomas
Hematology NewsFDA approves rituximab biosimilar for cancer, autoimmune disordersJuly 23, 2019B Cell LymphomaCLLLymphoma & Plasma Cell DisordersFollicular Lymphoma
